Vistusertib
Vistusertib (AZD2014) is an orally active mTOR inhibitor with potential anticancer properties. It is used in preclinical research to study mTOR signaling in oncology, demonstrating activity in both in vitro cell-based assays and in vivo tumor models.
Product Specifications
CAS Number
1009298-59-2
Product Name Alternative
AZD 2014, AZD2014, AZD-2014, Autophagy, Apoptosis, Mammalian target of Rapamycin, Inhibitor, P-Akt (S473), inhibit, mTOR, pS6 (S235/236), S6 Kinase, S6Kinase, PI3Kα, Vistusertib
Field of Research
Cell Biology, Signal Transduction
Purity
97.08% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.32 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:36 mg/mL (77.83 mM)
Smiles
CNC (=O) c1cccc (c1) -c1ccc2c (nc (nc2n1) N1CCOC[C@@H]1C) N1CCOC[C@@H]1C
Molecular Formula
C25H30N6O3
Molecular Weight
462.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9220-Dylight594 100 µg
Anti-HRG Antibody Picoband® (Dylight594 Conjugate)
Sign In for Pricing
View Details